Skip to main content
Clinical Trials/NL-OMON52275
NL-OMON52275
Not yet recruiting
Not Applicable

Multimodal Optical-imaging of Retinal manifestations of Alzheimer*s Disease - MORAD

Vrije Universiteit Medisch Centrum0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's Disease
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 50 years
  • Mini Mental State Exam (MMSE) greater or equal to 17 (patients who are mentally
  • Available AD biomarker information

Exclusion Criteria

  • \- Pupil dilation inadequate or contraindicated
  • \- Presence of glaucoma, retinal vasculopathy (diabetic, hypertensive)
  • \- Presence of moderate / late\-stage age\-related macular degeneration
  • \- Media opacities (cataract) precluding good quality imaging
  • \- Refractive error outside the range \-6D to \+6D
  • \- Inability to obtain good quality images with the OCT(\-A), widefield fundus
  • photography and metabolic hyperspectral retinal camera
  • \- Ocular conditions including eye infection, eye inflammation, eye surgery
  • last 28 days or other acute eye conditions.
  • Presence of other neurodegenerative disease (i.e. other causes of dementia, MS,

Outcomes

Primary Outcomes

Not specified

Similar Trials